Chronic inflammation and altered estrogen metabolism create a microenvironment that supports estrogen receptor-positive breast cancer progression in aging women. This research identifies specific biological mechanisms linking systemic aging processes to increased cancer susceptibility, establishing targets for intervention before malignancy develops.
Key Points
- Systemic and local inflammation drives tumor-permissive conditions in aging
- Altered estrogen metabolism accelerates ER+ breast cancer progression
- Age-related changes in hormone disposition increase cancer vulnerability
Longevity Analysis
The research demonstrates that cancer risk in older women reflects not inevitable cellular decline but rather a correctable imbalance in how the body manages inflammation and metabolizes hormones. Rather than treating cancer as a discrete disease event, this work suggests the precancerous environment develops across years through two interconnected processes: unresolved inflammatory signaling and dysregulated estrogen handling. For practitioners and individuals focused on sustained health, this means the prevention window exists well before tumor detection — by addressing chronic inflammatory drivers and supporting efficient hormone metabolism during midlife transitions, the conditions that permit malignant transformation can be substantially altered.
Original published by Nature Aging, by Neil Carleton.